V
AGN

Veritable’s Allergan plc AGN Stock Holding History

Veritable’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,856
Closed -$1.21M – 797
2020
Q1 		$1.21M Sell
6,856
-962
-12% -$181K 0.03% 262
2019
Q4 		$1.5M Sell
7,818
-434
-5% -$78.3K 0.03% 283
2019
Q3 		$1.39M Buy
8,252
+740
+10% +$121K 0.03% 277
2019
Q2 		$1.26M Buy
7,512
+697
+10% +$96.5K 0.03% 299
2019
Q1 		$998K Buy
6,815
+1,007
+17% +$146K 0.02% 343
2018
Q4 		$776K Sell
5,808
-4,410
-43% -$723K 0.02% 364
2018
Q3 		$1.95M Buy
10,218
+223
+2% +$41K 0.04% 221
2018
Q2 		$1.67M Sell
9,995
-1,361
-12% -$218K 0.04% 239
2018
Q1 		$1.91M Buy
11,356
+1,753
+18% +$294K 0.04% 212
2017
Q4 		$1.57M Sell
9,603
-1,438
-13% -$258K 0.03% 252
2017
Q3 		$2.26M Sell
11,041
-914
-8% -$213K 0.05% 200
2017
Q2 		$2.91M Buy
11,955
+1,317
+12% +$309K 0.07% 173
2017
Q1 		$2.54M Buy
10,638
+925
+10% +$215K 0.06% 179
2016
Q4 		$2.04M Sell
9,713
-771
-7% -$160K 0.05% 204
2016
Q3 		$2.42M Buy
10,484
+1,262
+14% +$308K 0.06% 172
2016
Q2 		$2.13M Sell
9,222
-3,212
-26% -$741K 0.05% 185
2016
Q1 		$3.33M Sell
12,434
-2,217
-15% -$635K 0.09% 132
2015
Q4 		$4.58M Buy
14,651
+205
+1% +$61K 0.13% 113
2015
Q3 		$3.93M Sell
14,446
-240
-2% -$73.7K 0.12% 126
2015
Q2 		$4.46M Sell
14,686
-3,714
-20% -$1.11M 0.12% 120
2015
Q1 		$5.48M Buy
18,400
+7,715
+72% +$2.2M 0.11% 140
2014
Q4 		$2.75M Buy
10,685
+717
+7% +$179K 0.06% 212
2014
Q3 		$2.4M Buy
9,968
+5,754
+137% +$1.29M 0.05% 234
2014
Q2 		$940K Buy
4,214
+682
+19% +$141K 0.02% 428
2014
Q1 		$727K Buy
3,532
+127
+4% +$25.2K 0.02% 477
2013
Q4 		$572K Buy
3,405
+114
+3% +$17.8K 0.01% 540
2013
Q3 		$474K Sell
3,291
-29
-0.9% -$3.86K 0.01% 595
2013
Q2 		$419K Buy
+3,320
New +$376K 0.01% 628

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Veritable's AGN Position: Q2 2020 in Review

Veritable sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,856 shares — an estimated $1.21M sold.

Veritable first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $5.48M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Veritable reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Veritable sold 6,856 Allergan plc shares in Q2 2020, an estimated $1.21M.
  • Veritable first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Veritable's Allergan plc position peaked at $5.48M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Veritable's 13F filing for Q2 2020, filed 14 Aug 2020.